These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Omega-3 polyunsaturated fatty acids. Hull MA Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):547-54. PubMed ID: 22122770 [TBL] [Abstract][Full Text] [Related]
8. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial. Ishikawa H; Wakabayashi K; Suzuki S; Mutoh M; Hirata K; Nakamura T; Takeyama I; Kawano A; Gondo N; Abe T; Tokudome S; Goto C; Matsuura N; Sakai T Cancer Med; 2013 Feb; 2(1):50-6. PubMed ID: 24133627 [TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442 [TBL] [Abstract][Full Text] [Related]
10. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132 [TBL] [Abstract][Full Text] [Related]
11. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. Cole BF; Logan RF; Halabi S; Benamouzig R; Sandler RS; Grainge MJ; Chaussade S; Baron JA J Natl Cancer Inst; 2009 Feb; 101(4):256-66. PubMed ID: 19211452 [TBL] [Abstract][Full Text] [Related]
12. The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations. Atkin W; Brenner A; Martin J; Wooldrage K; Shah U; Lucas F; Greliak P; Pack K; Kralj-Hans I; Thomson A; Perera S; Wood J; Miles A; Wardle J; Kearns B; Tappenden P; Myles J; Veitch A; Duffy SW Health Technol Assess; 2017 Apr; 21(25):1-536. PubMed ID: 28621643 [TBL] [Abstract][Full Text] [Related]
13. Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. West NJ; Clark SK; Phillips RK; Hutchinson JM; Leicester RJ; Belluzzi A; Hull MA Gut; 2010 Jul; 59(7):918-25. PubMed ID: 20348368 [TBL] [Abstract][Full Text] [Related]
14. ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial. Drew DA; Chin SM; Gilpin KK; Parziale M; Pond E; Schuck MM; Stewart K; Flagg M; Rawlings CA; Backman V; Carolan PJ; Chung DC; Colizzo FP; Freedman M; Gala M; Garber JJ; Huttenhower C; Kedrin D; Khalili H; Kwon DS; Markowitz SD; Milne GL; Nishioka NS; Richter JM; Roy HK; Staller K; Wang M; Chan AT Trials; 2017 Feb; 18(1):50. PubMed ID: 28143522 [TBL] [Abstract][Full Text] [Related]
15. Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial. Fuller H; Race AD; Fenton H; Burke L; Downing A; Williams EA; Rees CJ; Brown LC; Loadman PM; Hull MA Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102570. PubMed ID: 37003144 [TBL] [Abstract][Full Text] [Related]
16. Effect of chemoprevention by low-dose aspirin of new or recurrent colorectal adenomas in patients with Lynch syndrome (AAS-Lynch): study protocol for a multicenter, double-blind, placebo-controlled randomized controlled trial. Soualy A; Deutsch D; Benallaoua M; Ait-Omar A; Mary F; Helfen S; Boubaya M; Levy V; Benamouzig R; Trials; 2020 Sep; 21(1):764. PubMed ID: 32887653 [TBL] [Abstract][Full Text] [Related]
17. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study. Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015 [TBL] [Abstract][Full Text] [Related]
18. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial. Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492 [TBL] [Abstract][Full Text] [Related]
19. The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients. Petrera M; Paleari L; Clavarezza M; Puntoni M; Caviglia S; Briata IM; Oppezzi M; Mislej EM; Stabuc B; Gnant M; Bachleitner-Hofmann T; Roth W; Scherer D; Haefeli WE; Ulrich CM; DeCensi A BMC Cancer; 2018 Dec; 18(1):1210. PubMed ID: 30514262 [TBL] [Abstract][Full Text] [Related]